Drug recall
Remicade (infliximab) recombinant for IV Injection, (20 ml vial)
FDA recall event 25046 · Class III · Centocor Inc
Key facts
| Event ID | 25046 |
|---|---|
| Recall numbers | B-0660-3 |
| Recalling firm | Centocor Inc |
| Product type | Biologics |
| Products | Remicade (infliximab) recombinant for IV Injection, (20 ml vial) |
| Classification | Class III |
| Status | Completed |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Products, which potentially lack specified vacuum in the vial, were released. |
| Initiation date | Nov 18, 2002 |
| City | Malvern |
| Country | United States |
| FEI number | 3001610451 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports